Eterna Therapeutics
Price & Volume
Stats
See more52W Range | $1.09-$11.10 |
Market Cap | $10.5M |
Shares Short | 713,392 |
Financials
See moreRevenue (12 Mos) | $1,000 |
Revenue Growth (YoY) | -94.1% |
Gross Profit (12 Mos) | $1,000 |
Diluted EPS | $56.32 |
News
See moreYahoo Finance • 15 days ago
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials
Yahoo Finance • 19 days ago
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform
Yahoo Finance • 27 days ago
BC-Most Active Stocks
Yahoo Finance • 2 months ago
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa
About
CEO | Mr. Sanjeev Luther |
Address | 1035 Cambridge Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
